Please assess the completion status of the following clinical trial:

Trial Title: Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* adult (\>=18 years of age) heart transplant patients (4-6 weeks post-transplant);~* receipt of first heart (single-organ) transplant;~* standard care regimen of CNI, MMF, and corticosteroids since transplantation.~Exclusion Criteria:~* positive donor-specific cross-match at time of transplantation;~* history of malignancies, other than non-melanoma skin cancer that has been totally excised with no recurrence for 2 years;~* patients participating in another interventional clinical trial or requiring treatment with unmarketed investigational drugs.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): 1

Based on this trial design, predict the completion outcome and termination type (if applicable).